Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Sep-Oct;43(5):462-464.
doi: 10.1590/1516-4446-2020-0024.

Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses

Rodrigo Machado-Vieira  1   2 , João Quevedo  2   3   4   5 , Lokesh Shahani  2 , Jair C Soares  1   2   4
Affiliations
Editorial

Convergent evidence for the antiviral effects of several FDA-approved phenothiazine antipsychotics against SARS-CoV-2 and other coronaviruses

Rodrigo Machado-Vieira et al. Braz J Psychiatry. 2021 Sep-Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

RM-V has received consulting fees from Eurofarma Pharmaceuticals and BioStrategies Group; has research contracts with Janssen Pharmaceuticals; has received speaker fees from Otsuka and Cristalia; is a member of the scientific board of Symbinas Pharmaceuticals; and receives copyright from Elsevier/Academic Press. JQ has received clinical research support from LivaNova; has been in the speaker bureau for Myriad Neuroscience, Janssen Pharmaceuticals, and Abbvie; is a partner at Instituto de Neurociências Dr. Joao Quevedo; and receives copyright from Artmed Editora, Artmed Panamericana, and Elsevier/Academic Press. The other authors report no conflicts of interest.

References

    1. Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, et al. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014;58:4885–93. - PMC - PubMed
    1. Weston S, Coleman CM, Haupt R, Logue J, Matthews K, Frieman MB. Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo. bioRxiv. 2020 doi: 10.1101/2020.03.25.008482. - DOI - PMC - PubMed
    1. National Center for Advancing Translational Sciences (NCATS) OpenDataPortal. OpenData COVID-19 [Internet] 2020. [cited 2020 Dec 10]. opendata.ncats.nih.gov/covid19/
    1. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–90. - PMC - PubMed
    1. Gorshkov K, Chen CZ, Bostwick R, Rasmussen L, Xu M, Pradhan M, et al. The SARS-CoV-2 cytopathic effect isblocked with autophagy modulators. Version 2. bioRxiv. Preprint. 2020 May 28 doi: 10.1101/2020.05.16.091520. - DOI

Publication types